IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 3416 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1The risks of PPI therapy
Paul Moayyedi,Grigorios I. Leontiadis
Nature Reviews Gastroenterology & Hepatology.2012;9(3)132
[DOI]
2ADP-Receptor Inhibitors in the Perioperative Period: The Good, the Bad, and the Ugly
Adriana Dana Oprea,Wanda M. Popescu
Journal of Cardiothoracic and Vascular Anesthesia.2013;27(4)779
[DOI]
3Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters
Kelly Bleasby,Robert Houle,Michael Hafey,Meihong Lin,Jingjing Guo,Bing Lu,Rosa I. Sanchez,Kerry L. Fillgrove
Viruses.2021;13(8)1566
[DOI]
4Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters
A. Vidya,M. Kalaivani,K. R. Venugopal,L M Patnaik
Viruses.2014;13(8)35
[DOI]
5Recent Safety Concerns With Proton Pump Inhibitors
Joan Chen,Yuhong Cathy Yuan,Grigorios I. Leontiadis,Colin W. Howden
Journal of Clinical Gastroenterology.2012;46(2)93
[DOI]
6Inconsistencies surrounding the risk of adverse outcomes with concomitant use of clopidogrel and proton pump inhibitors
Chun Shing Kwok,Yoon Kong Loke
Expert Opinion on Drug Safety.2012;11(2)275
[DOI]
7Efficacy, Safety, and Tolerability of Pantoprazole Magnesium in the Treatment of Reflux Symptoms in Patients with Gastroesophageal Reflux Disease (GERD): A Prospective, Multicenter, Post-Marketing Observational Study
José María Remes-Troche,Sergio Sobrino-Cossío,Julio César Soto-Pérez,Oscar Teramoto-Matsubara,Miguel Morales-Arámbula,Antonio Orozco-Gamiz,José Luis Tamayo de la Cuesta,Gualberto Mateos
Clinical Drug Investigation.2014;34(2)83
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow